Europe Anti Obesity Drugs Market Report 2016

November 2016 | 119 pages | ID: E8E482AAE6BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies sales (consumption) of Anti Obesity Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Pfizer
• Merck
• Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Anti Obesity Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Anti Obesity Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Anti Obesity Drugs Market Report 2016

1 ANTI OBESITY DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Classification of Anti Obesity Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anti Obesity Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Anti Obesity Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Anti Obesity Drugs (2011-2021)
  1.5.1 Europe Anti Obesity Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE ANTI OBESITY DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Anti Obesity Drugs Market Competition by Manufacturers
  2.1.1 Europe Anti Obesity Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Anti Obesity Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Anti Obesity Drugs (Volume and Value) by Type
  2.2.1 Europe Anti Obesity Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Anti Obesity Drugs (Volume and Value) by Countries
  2.3.1 Europe Anti Obesity Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Anti Obesity Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Anti Obesity Drugs (Volume) by Application

3 GERMANY ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Anti Obesity Drugs Sales and Value (2011-2016)
  3.1.1 Germany Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Anti Obesity Drugs Sales Price Trend (2011-2016)
3.2 Germany Anti Obesity Drugs Sales and Market Share by Manufacturers
3.3 Germany Anti Obesity Drugs Sales and Market Share by Type
3.4 Germany Anti Obesity Drugs Sales and Market Share by Application

4 FRANCE ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Anti Obesity Drugs Sales and Value (2011-2016)
  4.1.1 France Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Anti Obesity Drugs Sales Price Trend (2011-2016)
4.2 France Anti Obesity Drugs Sales and Market Share by Manufacturers
4.3 France Anti Obesity Drugs Sales and Market Share by Type
4.4 France Anti Obesity Drugs Sales and Market Share by Application

5 UK ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Anti Obesity Drugs Sales and Value (2011-2016)
  5.1.1 UK Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Anti Obesity Drugs Sales Price Trend (2011-2016)
5.2 UK Anti Obesity Drugs Sales and Market Share by Manufacturers
5.3 UK Anti Obesity Drugs Sales and Market Share by Type
5.4 UK Anti Obesity Drugs Sales and Market Share by Application

6 RUSSIA ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Anti Obesity Drugs Sales and Value (2011-2016)
  6.1.1 Russia Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Anti Obesity Drugs Sales Price Trend (2011-2016)
6.2 Russia Anti Obesity Drugs Sales and Market Share by Manufacturers
6.3 Russia Anti Obesity Drugs Sales and Market Share by Type
6.4 Russia Anti Obesity Drugs Sales and Market Share by Application

7 ITALY ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Anti Obesity Drugs Sales and Value (2011-2016)
  7.1.1 Italy Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Anti Obesity Drugs Sales Price Trend (2011-2016)
7.2 Italy Anti Obesity Drugs Sales and Market Share by Manufacturers
7.3 Italy Anti Obesity Drugs Sales and Market Share by Type
7.4 Italy Anti Obesity Drugs Sales and Market Share by Application

8 SPAIN ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Anti Obesity Drugs Sales and Value (2011-2016)
  8.1.1 Spain Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Anti Obesity Drugs Sales Price Trend (2011-2016)
8.2 Spain Anti Obesity Drugs Sales and Market Share by Manufacturers
8.3 Spain Anti Obesity Drugs Sales and Market Share by Type
8.4 Spain Anti Obesity Drugs Sales and Market Share by Application

9 BENELUX ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Anti Obesity Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Anti Obesity Drugs Sales Price Trend (2011-2016)
9.2 Benelux Anti Obesity Drugs Sales and Market Share by Manufacturers
9.3 Benelux Anti Obesity Drugs Sales and Market Share by Type
9.4 Benelux Anti Obesity Drugs Sales and Market Share by Application

10 EUROPE ANTI OBESITY DRUGS MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Anti Obesity Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Merck
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Anti Obesity Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Roche
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Anti Obesity Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Anti Obesity Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 AstraZeneca
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Anti Obesity Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Boehringer Ingelheim
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Anti Obesity Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Anti Obesity Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Eisai
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Anti Obesity Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Norgine
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Anti Obesity Drugs Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Arena Pharmaceuticals
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Anti Obesity Drugs Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Orexigen Therapeutics
10.12 Vivus
10.13 Alizyme
10.14 Rhythm Pharmaceuticals
10.15 Shionogi
10.16 Zafgan

11 ANTI OBESITY DRUGS MANUFACTURING COST ANALYSIS

11.1 Anti Obesity Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anti Obesity Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Anti Obesity Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ANTI OBESITY DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Anti Obesity Drugs Sales Forecast (2016-2021)
14.2 France Anti Obesity Drugs Sales Forecast (2016-2021)
14.3 UK Anti Obesity Drugs Sales Forecast (2016-2021)
14.4 Russia Anti Obesity Drugs Sales Forecast (2016-2021)
14.5 Italy Anti Obesity Drugs Sales Forecast (2016-2021)
14.6 Spain Anti Obesity Drugs Sales Forecast (2016-2021)
14.7 Benelux Anti Obesity Drugs Sales Forecast (2016-2021)
14.8 Europe Anti Obesity Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Anti Obesity Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti Obesity Drugs
Table Classification of Anti Obesity Drugs
Figure Europe Sales Market Share of Anti Obesity Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Anti Obesity Drugs
Figure Europe Sales Market Share of Anti Obesity Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure France Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure UK Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Anti Obesity Drugs Sales and Growth Rate (2011-2021)
Figure Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Table Europe Anti Obesity Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Anti Obesity Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti Obesity Drugs Sales Share by Manufacturers
Figure 2016 Anti Obesity Drugs Sales Share by Manufacturers
Table Europe Anti Obesity Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Anti Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Anti Obesity Drugs Revenue Share by Manufacturers
Table 2016 Europe Anti Obesity Drugs Revenue Share by Manufacturers
Table Europe Anti Obesity Drugs Sales and Market Share by Type (2011-2016)
Table Europe Anti Obesity Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Anti Obesity Drugs by Type (2011-2016)
Figure Europe Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Anti Obesity Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti Obesity Drugs by Type (2011-2016)
Figure Europe Anti Obesity Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Anti Obesity Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Anti Obesity Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Anti Obesity Drugs by Countries (2011-2016)
Table Europe Anti Obesity Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Anti Obesity Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Anti Obesity Drugs by Countries (2011-2016)
Table Europe Anti Obesity Drugs Sales and Market Share by Application (2011-2016)
Table Europe Anti Obesity Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Anti Obesity Drugs by Application (2011-2016)
Figure Germany Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Germany Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Germany Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Anti Obesity Drugs Sales by Type (2015 and 2016)
Table Germany Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table Germany Anti Obesity Drugs Sales by Application (2015 and 2016)
Table Germany Anti Obesity Drugs Market Share by Application (2015 and 2016)
Figure France Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure France Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure France Anti Obesity Drugs Sales Price Trend (2011-2016)
Table France Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table France Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table France Anti Obesity Drugs Sales by Type (2015 and 2016)
Table France Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table France Anti Obesity Drugs Sales by Application (2015 and 2016)
Table France Anti Obesity Drugs Market Share by Application (2015 and 2016)
Figure UK Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure UK Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure UK Anti Obesity Drugs Sales Price Trend (2011-2016)
Table UK Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table UK Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Anti Obesity Drugs Sales by Type (2015 and 2016)
Table UK Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table UK Anti Obesity Drugs Sales by Application (2015 and 2016)
Table UK Anti Obesity Drugs Market Share by Application (2015 and 2016)
Figure Russia Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Russia Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Russia Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Anti Obesity Drugs Sales by Type (2015 and 2016)
Table Russia Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table Russia Anti Obesity Drugs Sales by Application (2015 and 2016)
Table Russia Anti Obesity Drugs Market Share by Application (2015 and 2016)
Figure Italy Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Italy Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Italy Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Anti Obesity Drugs Sales by Type (2015 and 2016)
Table Italy Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table Italy Anti Obesity Drugs Sales by Application (2015 and 2016)
Table Italy Anti Obesity Drugs Market Share by Application (2015 and 2016)
Figure Spain Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Spain Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Spain Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Anti Obesity Drugs Sales by Type (2015 and 2016)
Table Spain Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table Spain Anti Obesity Drugs Sales by Application (2015 and 2016)
Table Spain Anti Obesity Drugs Market Share by Application (2015 and 2016)
Figure Benelux Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Benelux Anti Obesity Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Anti Obesity Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Anti Obesity Drugs Sales by Type (2015 and 2016)
Table Benelux Anti Obesity Drugs Market Share by Type (2015 and 2016)
Table Benelux Anti Obesity Drugs Sales by Application (2015 and 2016)
Table Benelux Anti Obesity Drugs Market Share by Application (2015 and 2016)
Table Anti Obesity Drugs Basic Information List
Table Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti Obesity Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anti Obesity Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Anti Obesity Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Anti Obesity Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Anti Obesity Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Anti Obesity Drugs Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Anti Obesity Drugs Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Anti Obesity Drugs Sales Market Share (2011-2016)
Table Norgine Basic Information List
Table Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Norgine Anti Obesity Drugs Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information List
Table Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexigen Therapeutics Anti Obesity Drugs Sales Market Share (2011-2016)
Table Vivus Basic Information List
Table Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vivus Anti Obesity Drugs Sales Market Share (2011-2016)
Table Alizyme Basic Information List
Table Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alizyme Anti Obesity Drugs Sales Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)
Table Shionogi Basic Information List
Table Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shionogi Anti Obesity Drugs Sales Market Share (2011-2016)
Table Zafgan Basic Information List
Table Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zafgan Anti Obesity Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti Obesity Drugs
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Anti Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti Obesity Drugs
Table Distributors/Traders List
Figure Germany Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Anti Obesity Drugs Sales Forecast by Type (2016-2021)
Table Europe Anti Obesity Drugs Sales Forecast by Application (2016-2021 )